Skip to main content
Log in

Multimodal analgesia did not improve post-operative pain scores, reduce opioid consumption or reduce length of stay following hip arthroscopy

  • HIP
  • Published:
Knee Surgery, Sports Traumatology, Arthroscopy Aims and scope

Abstract

Purpose

To determine whether different regimens of multimodal analgesia will reduce postoperative pain scores, opioid consumption, costs and hospital length-of-stay following hip arthroscopy.

Methods

From 2018 to 2021, 132 patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) were included in this prospective, single-center randomized controlled trial. Patients were randomized into four treatment groups:

  1. (1)

    Group 1—Control: opioid medication (oxycodone-acetaminophen 5 mg/325 mg, 1–2 tabs q6H as needed), Heterotopic ossification prophylaxis—Naprosyn 500 mg twice daily × 3 weeks);

  2. (2)

    Group 2—Control + postoperative sleeping aid (Zopiclone 7.5 mg nightly × 7 days);

  3. (3)

    Group 3—Control + preoperative and postoperative Gabapentin (600 mg orally, 1 h preoperatively; 600 mg postoperatively, 8 h following pre-op dose);

  4. (4)

    Group 4—Control + pre-medicate with Celecoxib (400 mg orally, 1 h preoperatively)

The primary outcome was pain measured with a visual analog scale, monitored daily for the first week and every other day for 6 weeks. Secondary outcomes included opioid consumption, healthcare resource use, and hospital length of stay.

Results

Patient characteristics were similar between groups. There were no statistically significant differences in pain scores between groups at any timepoint after adjusting for intra-operative traction time, intra-operative opioid administration and preoperative pain scores (p > 0.05). There were also no significant differences in the number of days that opioids were taken (n.s.) and the average daily morphine milligram equivalents consumed (n.s.). Similarly, there were no statistically significant differences in length of stay in the experimental groups, compared with the control group (n.s.). Finally, there were no differences in cost between groups (n.s.).

Conclusion

The routine use of Zopiclone, Celecoxib and Gabapentin did not improve postoperative pain control or reduce length-of-stay following hip arthroscopy. Therefore, these medications are not recommended for routine postoperative pain control following hip arthroscopy.

Level of evidence

l.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data of this study are available from the corresponding author upon request.

References:

  1. Abebe MM, Arefayne NR, Temesgen MM, Admass BA (2022) Evidence-based perioperative pain management protocol for day case surgery in a resource limited setting: systematic review. Ann Med Surg. https://doi.org/10.1016/j.amsu.2022.104322

    Article  Google Scholar 

  2. Acuña AJ, Jella TK, Samuel LT, Cwalina TB, Kim TS, Kamath AF (2021) A work in progress: national opioid prescription reductions across orthopaedic subspecialties in a contemporary medicare sample of 5,026,911 claims. J Am Acad Orthop Surg Glob Res Rev 5:1–12. https://doi.org/10.5435/JAAOSGlobal-D-21-00080

    Article  Google Scholar 

  3. Bronstone AB, Leonardi C, Kubilay T, Plessl DS, Morreale PJ, Tortorich GM, Krause PC (2022) Dramatic reduction in opioid prescribing for common outpatient orthopaedic lower extremity surgical procedures at a Louisiana University-Based Safety-Net Hospital after enactment of opioid-limiting state legislation. J Am Acad Orthop Surg 30:e405–e414. https://doi.org/10.5435/JAAOS-D-21-00390

    Article  PubMed  Google Scholar 

  4. Cunningham DJ, George SZ, Lewis BD (2020) The impact of state level public policy, prescriber education, and patient factors on opioid prescribing in elective orthopedic surgery: findings from a tertiary, academic setting. Mayo Clin Proc Innov Qual Outcomes 5:23–34

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cunningham DJ, Kwon NF, Allen NB, Hanselman AM, Adams SB (2021) Time and state legislation have decreased opioid prescribing in elective foot and ankle surgery in the United States. Foot Ankle Spec. https://doi.org/10.1177/19386400211043361

    Article  PubMed  Google Scholar 

  6. Dold AP, Murnaghan L, Xing J, Abdallah FW, Brull R, Whelan DB (2014) Preoperative femoral nerve block in hip arthroscopic surgery: a retrospective review of 108 consecutive cases. Am J Sports Med 42:144–149

    Article  PubMed  Google Scholar 

  7. Ekman EF, Wahba M, Ancona F (2006) Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study. Arthroscopy 22:635–642

    Article  PubMed  Google Scholar 

  8. Garner M, Alsheemeri Z, Sardesai A, Khanduja V (2017) A prospective randomized controlled trial comparing the efficacy of fascia iliaca compartment block versus local anesthetic infiltration after hip arthroscopic surgery. Arthroscopy 33:125–132

    Article  PubMed  Google Scholar 

  9. Huang Y-M, Wang C-M, Wang C-T, Lin W-P, Horng L-C, Jiang C-C (2008) Perioperative celecoxib administration for pain management after total knee arthroplasty—a randomized, controlled study. BMC Musculoskelet Disord. https://doi.org/10.1186/1471-2474-9-77

    Article  PubMed  PubMed Central  Google Scholar 

  10. Jones CA, Throckmorton TW, Murphy J, Eason RR, Joyce M, Bernholt DL, Azar FM, Brolin TJ (2022) Opioid-sparing pain management protocol after shoulder arthroplasty results in less opioid consumption and higher satisfaction: a prospective, randomized controlled trial. J Shoulder Elbow Surg 31:2057–2065

    Article  PubMed  Google Scholar 

  11. Kahlenberg CA, Patel RM, Knesek M, Tjong VK, Sonn K, Terry MA (2017) Efficacy of Celecoxib for early postoperative pain management in hip arthroscopy: a prospective randomized placebo-controlled study. Arthroscopy 33:1180–1185

    Article  PubMed  Google Scholar 

  12. Kay J, De Sa D, Memon M, Simunovic N, Paul J, Ayeni OR (2016) Examining the role of perioperative nerve blocks in hip arthroscopy: a systematic review. Arthroscopy 32:704–715

    Article  PubMed  Google Scholar 

  13. Kumar V, Kaur K, Gupta GK, Gupta AK, Kumar S (2013) Developments in synthesis of the anti-inflammatory drug, celecoxib: a review. Recent Pat Inflamm Allergy Drug Discov 7:124–134

    Article  CAS  PubMed  Google Scholar 

  14. Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL (2021) Morbidity and mortality weekly report trends and geographic patterns in drug and synthetic opioid overdose deaths-United States, 2013–2019. Morb Mortal Wkly Rep 70:202–207

    Article  Google Scholar 

  15. Ménigaux C, Adam F, Guignard B, Sessler DI, Chauvin M (2005) Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery. Anesth Analg 100:1394–1399

    Article  PubMed  PubMed Central  Google Scholar 

  16. NO PAin Investigators, Gazendam A, Ekhtiari S, Horner NS, Simunovic N, Khan M, de Sa DL, Madden K, Ayeni OR (2022) Effect of a postoperative multimodal opioid-sparing protocol vs standard opioid prescribing on postoperative opioid consumption after knee or shoulder arthroscopy: a randomized clinical trial. JAMA 328:1326–1335

    Article  Google Scholar 

  17. Nye ZB, Horn JL, Crittenden W, Abrahams MS, Aziz MF (2013) Ambulatory continuous posterior lumbar plexus blocks following hip arthroscopy: a review of 213 cases. J Clin Anesth 25:268–274

    Article  PubMed  Google Scholar 

  18. O’Hagan ET, Hübscher M, Miller CB, Gordon CJ, Gustin S, Briggs N, McAuley JH (2020) Zolpidem reduces pain intensity postoperatively: a systematic review and meta-analysis of the effect of hypnotic medicines on post-operative pain intensity. Syst Rev. https://doi.org/10.1186/s13643-020-01458-8

    Article  PubMed  PubMed Central  Google Scholar 

  19. Olsen MF, Bjerre E, Hansen MD, Hilden J, Landler NE, Tendal B, Hróbjartsson A (2017) Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Med. https://doi.org/10.1186/s12916-016-0775-3

    Article  PubMed  PubMed Central  Google Scholar 

  20. Pasqualini I, Rullán PJ, Deren M, Krebs VE, Molloy RM, Nystrom LM, Piuzzi NS (2023) Team approach: use of opioids in orthopaedic practice. JBJS Rev. https://doi.org/10.2106/JBJS.RVW.22.00209

    Article  PubMed  Google Scholar 

  21. Paul RW, Szukics PF, Brutico J, Tjoumakaris FP, Freedman KB (2022) Postoperative multimodal pain management and opioid consumption in arthroscopy clinical trials: a systematic review. Arthrosc Sport Med Rehabil 4:e721–e746

    Google Scholar 

  22. Peng C, Li C, Qu J, Wu D (2017) Gabapentin can decrease acute pain and morphine consumption in spinal surgery patients. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000006463

    Article  PubMed  PubMed Central  Google Scholar 

  23. Randall DJ, Vanood A, Jee Y, Moore DD (2022) National and state level opioid-restricting legislation in total joint arthroplasty: a systematic review. J Arthroplasty 37:176–185

    Article  PubMed  Google Scholar 

  24. Rose MA, Kam PCA (2002) Gabapentin:pharmacology and its use in pain management. Anaesthesia 57:451–462

    Article  CAS  PubMed  Google Scholar 

  25. Rossi MJ (2021) Editorial commentary: opioid sparing through patient education programs is the future for sports medicine and arthroscopic surgery to optimize outcome. Arthroscopy 37:1573–1576

    Article  PubMed  Google Scholar 

  26. Federal, provincial, and territorial Special Advisory Committee on the epidemic of opioid overdoses. Opioid- and stimulant-related harms in Canada. Public Health Agency of Canada, Ottawa, 2023. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/

  27. Su L, Garcia-Mansilla I, Kelley B, Arshi A, Fabricant PD, Sherman SL, Jones KJ (2022) Clinical outcomes of meniscal allograft transplantation with respect to the minimal clinically important difference. Am J Sports Med 50:3440–3446

    Article  PubMed  Google Scholar 

  28. Tashjian RZ, Banerjee R, Bradley MP, Alford W, Fadale PD (2006) Zolpidem reduces postoperative pain, fatigue, and narcotic consumption following knee arthroscopy: a prospective randomized placebo-controlled double-blinded study. J Knee Surg 19:105–111

    Article  PubMed  Google Scholar 

  29. Tompkins M, Plante M, Monchik K, Fleming B, Fadale P (2011) The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial. Knee Surg Sports Traumatol Arthrosc 19:787–791

    Article  PubMed  Google Scholar 

  30. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M (2005) Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 64:29–33

    Article  CAS  PubMed  Google Scholar 

  31. Xing JG, Abdallah FW, Brull R, Oldfield S, Dold A, Murnaghan ML, Whelan DB (2015) Preoperative femoral nerve block for hip arthroscopy. Am J Sports Med 43:2680–2687

    Article  PubMed  Google Scholar 

  32. YaDeau JT, Tedore T, Goytizolo EA, Kim DH, Green DST, Westrick A, Fan R, Rade MC, Ranawat AS, Coleman SH, Kelly BT (2012) Lumbar plexus blockade reduces pain after hip arthroscopy: a prospective randomized controlled trial. Anesth Analg 115:968–972

    Article  PubMed  Google Scholar 

  33. Zhang AL, Feeley BT (2018) Editorial commentary: the rise of hip arthroscopy: temporary trend or here to stay? Arthroscopy 34:1831–1832

    Article  PubMed  Google Scholar 

  34. Zhang Z, Zhu W, Zhu L, Du Y (2014) Efficacy of celecoxib for pain management after arthroscopic surgery of hip: a prospective randomized placebo-controlled study. Eur J Orthop Surg Traumatol 24:919–923

    Article  PubMed  Google Scholar 

Download references

Funding

The authors would like to acknowledge the Lawson Health Research Institute for their support of this research through an Internal Research Fund (#F06-19).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryan M. Degen.

Ethics declarations

Conflict of interest

None.

Ethical approval

This study was registered with http://www.clinicaltrials.gov (NCT03351439) and approved by our institutional review board (Western University Health Sciences REB ID# 110350).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Degen, R.M., Firth, A., Sehmbi, H. et al. Multimodal analgesia did not improve post-operative pain scores, reduce opioid consumption or reduce length of stay following hip arthroscopy. Knee Surg Sports Traumatol Arthrosc 31, 4016–4026 (2023). https://doi.org/10.1007/s00167-023-07445-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00167-023-07445-5

Keywords

Navigation